{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:01:50Z","timestamp":1792677710002,"version":"4.5.0"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bestpracticeobgyn.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.bpobgyn.2016.05.003","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T08:36:11Z","timestamp":1463819771000},"page":"98-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"special_numbering":"C","title":["Androgen excess: Investigations and management"],"prefix":"10.1016","volume":"37","author":[{"given":"Daria","family":"Lizneva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Gavrilova-Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walidah","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Azziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bpobgyn.2016.05.003_bib1","first-page":"221","article-title":"Regulation of the acute production of steroids in steroidogenic cells","volume":"17","author":"Stocco","year":"1996","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bpobgyn.2016.05.003_bib2","series-title":"Androgen excess disorders in women: polycystic ovary syndrome and other disorders","author":"Azziz","year":"2006"},{"issue":"14","key":"10.1016\/j.bpobgyn.2016.05.003_bib3","doi-asserted-by":"crossref","first-page":"13265","DOI":"10.1074\/jbc.M414673200","article-title":"Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17","volume":"280","author":"Pandey","year":"2005","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.bpobgyn.2016.05.003_bib4","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.273.6.3158","article-title":"Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer","volume":"273","author":"Auchus","year":"1998","journal-title":"J Biol Chem"},{"issue":"1\u20133","key":"10.1016\/j.bpobgyn.2016.05.003_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000179774","article-title":"Regulation of gonadal androgen secretion","volume":"18","author":"Franchimont","year":"1983","journal-title":"Horm Res"},{"issue":"17","key":"10.1016\/j.bpobgyn.2016.05.003_bib6","doi-asserted-by":"crossref","first-page":"12964","DOI":"10.1016\/S0021-9258(18)31480-7","article-title":"Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity","volume":"268","author":"Wu","year":"1993","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.bpobgyn.2016.05.003_bib7","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1210\/jc.2002-021875","article-title":"Beyond adrenal and ovarian androgen generation: increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome","volume":"88","author":"Fassnacht","year":"2003","journal-title":"J\u00a0Clin Endocr Metab"},{"issue":"3","key":"10.1016\/j.bpobgyn.2016.05.003_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/edrv-9-3-295","article-title":"Molecular biology of steroid hormone synthesis","volume":"9","author":"Miller","year":"1988","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.05.003_bib9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0015-0282(98)00536-6","article-title":"Adrenal androgen excess in hyperandrogenism: relation to age and body mass","volume":"71","author":"Moran","year":"1999","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.05.003_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/edrv.21.4.0404","article-title":"Role of hormones in pilosebaceous unit development","volume":"21","author":"Deplewski","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bpobgyn.2016.05.003_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1749-6632.2001.tb04001.x","article-title":"Androgen receptor: structural domains and functional dynamics after ligand-receptor interaction","volume":"949","author":"Roy","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0300-595X(86)80021-4","article-title":"Adrenal and gonadal androgen secretion in normal females","volume":"15","author":"Longcope","year":"1986","journal-title":"Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.bpobgyn.2016.05.003_bib13","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1373\/49.8.1381","article-title":"Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children","volume":"49","author":"Taieb","year":"2003","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.bpobgyn.2016.05.003_bib14","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1093\/humrep\/del175","article-title":"Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS","volume":"21","author":"Chen","year":"2006","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.05.003_bib15","first-page":"48","article-title":"Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women","volume":"85","author":"Parker","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.bpobgyn.2016.05.003_bib16","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1210\/jcem-49-5-730","article-title":"Testosterone binding and free plasma androgen concentrations under physiological conditons: chararacterization by flow dialysis technique","volume":"49","author":"Moll","year":"1979","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0009-9120(99)00091-0","article-title":"Urinary steroids in women with androgenic alopecia","volume":"33","author":"Juricskay","year":"2000","journal-title":"Clin Biochem"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.bpobgyn.2016.05.003_bib19","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.05.003_bib20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0015-0282(16)57474-3","article-title":"Ovarian influence on adrenal androgen secretion in polycystic ovary syndrome","volume":"63","author":"Fruzzetti","year":"1995","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.bpobgyn.2016.05.003_bib21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0015-0282(16)61020-8","article-title":"Reproductive endocrinologic alterations in female asymptomatic obesity","volume":"52","author":"Azziz","year":"1989","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.bpobgyn.2016.05.003_bib22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.16.3.322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion","volume":"16","author":"Ehrmann","year":"1995","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.bpobgyn.2016.05.003_bib23","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.fertnstert.2008.02.101","article-title":"Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome","volume":"91","author":"Brennan","year":"2009","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.fertnstert.2008.06.021","article-title":"Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS","volume":"92","author":"Landay","year":"2009","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.bpobgyn.2016.05.003_bib25","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","article-title":"Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus","volume":"77","author":"Ovalle","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.05.003_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/S0015-0282(03)01924-1","article-title":"Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS) using age-specific DHEAS levels adjusted for body mass and ethnicity","volume":"80","author":"Kumar","year":"2003","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.bpobgyn.2016.05.003_bib27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/09513590.2011.650770","article-title":"Impact of adrenal versus ovarian androgen ratio on signs and symptoms of polycystic ovarian syndrome","volume":"28","author":"Kosus","year":"2012","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0300-595X(86)80029-9","article-title":"Pilosebaceous physiology in relation to hirsutism and acne","volume":"15","author":"Rosenfield","year":"1986","journal-title":"Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.05.003_bib29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2265.1994.tb02483.x","article-title":"Androgens and human hair growth","volume":"40","author":"Randall","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.bpobgyn.2016.05.003_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1087-0024.2005.10106.x","article-title":"Hirsutism and the variable response of the pilosebaceous unit to androgen","volume":"10","author":"Rosenfield","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.05.003_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.bpobgyn.2016.05.003_bib32","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.fertnstert.2006.02.069","article-title":"The spectrum of androgen excess disorders","volume":"85","author":"Carmina","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.05.003_bib33","article-title":"The association of androgen levels with the severity of hirsutism in the polycystic ovary syndrome (PCOS)","volume":"86","author":"Huang","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.05.003_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jsbmb.2014.06.003","article-title":"DHEA, DHEAS and PCOS","volume":"145","author":"Goodarzi","year":"2015","journal-title":"J\u00a0Steroid Biochem"},{"issue":"5","key":"10.1016\/j.bpobgyn.2016.05.003_bib35","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0015-0282(01)01701-0","article-title":"Hyperandrogenemia in patients presenting with acne","volume":"75","author":"Slayden","year":"2001","journal-title":"Fertil Steril"},{"issue":"5 Pt 1","key":"10.1016\/j.bpobgyn.2016.05.003_bib36","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0190-9622(88)70108-5","article-title":"Patterned androgenic alopecia in women","volume":"18","author":"Venning","year":"1988","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2016.05.003_bib37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1490439","article-title":"Prevalence of polycystic ovaries in women with androgenic alopecia","volume":"149","author":"Cela","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.05.003_bib38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/humupd\/dmp024","article-title":"Visually scoring hirsutism","volume":"16","author":"Yildiz","year":"2010","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.05.003_bib39","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1210\/jc.2004-2301","article-title":"Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism","volume":"91","author":"DeUgarte","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.bpobgyn.2016.05.003_bib40","first-page":"459","article-title":"Clinical diagnosis of hirsutism in Thai women","volume":"87","author":"Cheewadhanaraks","year":"2004","journal-title":"J\u00a0Med Assoc Thai"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.05.003_bib41","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000277640","article-title":"Prevalence of polycystic ovary syndrome and related disorders in Mexican women","volume":"69","author":"Moran","year":"2010","journal-title":"Gynecol Obstet Invest"},{"issue":"5","key":"10.1016\/j.bpobgyn.2016.05.003_bib42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2012.39","article-title":"Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999\u20132010","volume":"307","author":"Flegal","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.bpobgyn.2016.05.003_bib43","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.fertnstert.2011.06.040","article-title":"Defining hirsutism in Chinese women: a cross-sectional study","volume":"96","author":"Zhao","year":"2011","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.bpobgyn.2016.05.003_bib44","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.ajog.2004.06.064","article-title":"The prevalence of androgen excess among patients with minimal unwanted hair growth","volume":"191","author":"Souter","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2016.05.003_bib45","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.05.003_bib46","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/humrep\/deq303","article-title":"Assessment of hirsutism among Korean women: results of a randomly selected sample of women seeking pre-employment physical check-up","volume":"26","author":"Kim","year":"2011","journal-title":"Hum Reprod"},{"issue":"1 Suppl","key":"10.1016\/j.bpobgyn.2016.05.003_bib47","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","article-title":"Management of acne: a report from a Global Alliance to Improve Outcomes in Acne","volume":"49","author":"Gollnick","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.bpobgyn.2016.05.003_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04374.x","article-title":"European evidence-based (S3) guidelines for the treatment of acne","volume":"26","author":"Nast","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2016.05.003_bib49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","article-title":"Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex","volume":"97","author":"Ludwig","year":"1977","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1067\/mjd.2003.81","article-title":"Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss","volume":"48","author":"Olsen","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib51","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaad.2004.04.008","article-title":"Evaluation and treatment of male and female pattern hair loss","volume":"52","author":"Olsen","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"Suppl 6","key":"10.1016\/j.bpobgyn.2016.05.003_bib52","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1610-0379.2011.07802.x","article-title":"Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men","volume":"9","author":"Blumeyer","year":"2011","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"14","key":"10.1016\/j.bpobgyn.2016.05.003_bib53","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.steroids.2013.09.002","article-title":"The effects of saliva collection, handling and storage on salivary testosterone measurement","volume":"78","author":"Durdiakova","year":"2013","journal-title":"Steroids"},{"issue":"6","key":"10.1016\/j.bpobgyn.2016.05.003_bib54","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1042\/bj0330931","article-title":"The isolation of 17-ketosteroids from the urine of normal women","volume":"33","author":"Callow","year":"1939","journal-title":"Biochem J"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib55","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.bpobgyn.2016.05.003_bib56","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1158\/1055-9965.EPI-06-0765","article-title":"Standardization of steroid hormone assays: why, how, and when?","volume":"16","author":"Stanczyk","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib57","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.05.003_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2013.12.056","article-title":"Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria","volume":"101","author":"Salameh","year":"2014","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib59","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/humupd\/dmr042","article-title":"Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"18","author":"Escobar-Morreale","year":"2012","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.05.003_bib60","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/jc.2007-2437","article-title":"Evaluation and treatment of hirsutism in premenopausal women: An Endocrine Society clinical practice guideline","volume":"93","author":"Martin","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.bpobgyn.2016.05.003_bib61","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1210\/jc.2010-1123","article-title":"Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism","volume":"95","author":"Legro","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.bpobgyn.2016.05.003_bib62","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.contraception.2009.03.006","article-title":"Ovarian activity and safety of a novel levonorgestrel\/ethinyl estradiol continuous oral contraceptive regimen","volume":"80","author":"Archer","year":"2009","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.bpobgyn.2016.05.003_bib63","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/humupd\/dmi005","article-title":"Combined oral contraceptives in the treatment of polycystic ovary syndrome","volume":"11","author":"Vrbikova","year":"2005","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.05.003_bib64","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0002-9378(78)90771-8","article-title":"The effect of oral contraceptive treatment on the serum concentration of dehydroisoandrosterone sulfate","volume":"132","author":"Madden","year":"1978","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2016.05.003_bib65","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0015-0282(16)54291-5","article-title":"Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives","volume":"55","author":"Porcile","year":"1991","journal-title":"Fertil Steril"},{"issue":"1A","key":"10.1016\/j.bpobgyn.2016.05.003_bib66","doi-asserted-by":"crossref","first-page":"130S","DOI":"10.1016\/S0002-9343(99)80071-0","article-title":"The role of oral contraceptives in the treatment of hyperandrogenic disorders","volume":"98","author":"Burkman","year":"1995","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.bpobgyn.2016.05.003_bib67","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/BF03350769","article-title":"Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism","volume":"21","author":"Sahin","year":"1998","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"12","key":"10.1016\/j.bpobgyn.2016.05.003_bib68","first-page":"3412","article-title":"Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism","volume":"80","author":"Heiner","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.05.003_bib69","first-page":"CD005552","article-title":"Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome","author":"Costello","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib70","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1210\/jc.2007-2287","article-title":"Effects of continuous versus cyclical oral contraception: a randomized controlled trial","volume":"93","author":"Legro","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.bpobgyn.2016.05.003_bib71","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1365-4632.2007.03270.x","article-title":"The effect of eflornithine 13.9% cream on the bother and discomfort due to hirsutism","volume":"46","author":"Jackson","year":"2007","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2016.05.003_bib72","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.ajog.2005.02.067","article-title":"Effect of oral versus transdermal steroidal contraceptives on androgenic markers","volume":"192","author":"White","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.05.003_bib73","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/humupd\/dmt038","article-title":"The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis","volume":"20","author":"Zimmerman","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.05.003_bib74","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/humrep\/dei312","article-title":"Rosiglitazone and ethinyl estradiol\/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance","volume":"21","author":"Lemay","year":"2006","journal-title":"Hum Reprod"},{"issue":"7","key":"10.1016\/j.bpobgyn.2016.05.003_bib75","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.2007-0282","article-title":"Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome","volume":"92","author":"Luque-Ramirez","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7305","key":"10.1016\/j.bpobgyn.2016.05.003_bib76","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.bpobgyn.2016.05.003_bib77","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0010-7824(03)00027-1","article-title":"Efficacy of second versus third generation oral contraceptives in the treatment of hirsutism","volume":"67","author":"Breitkopf","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2016.05.003_bib78","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000341823","article-title":"Combined oral contraceptives in polycystic ovary syndrome \u2013 indications and cautions","volume":"40","author":"Bozdag","year":"2013","journal-title":"Front Horm Res"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.05.003_bib79","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/09637480601137066","article-title":"Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism","volume":"23","author":"Batukan","year":"2007","journal-title":"Gynecol Endocrinol"},{"issue":"12","key":"10.1016\/j.bpobgyn.2016.05.003_bib80","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1080\/09513590802454943","article-title":"Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations","volume":"24","author":"Lello","year":"2008","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.05.003_bib81","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.fertnstert.2012.06.035","article-title":"Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome","volume":"98","author":"Bhattacharya","year":"2012","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.bpobgyn.2016.05.003_bib82","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0015-0282(02)02993-X","article-title":"Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives","volume":"77","author":"Mastorakos","year":"2002","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.bpobgyn.2016.05.003_bib83","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0010-7824(95)00074-K","article-title":"Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation","volume":"51","author":"Rosenberg","year":"1995","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.bpobgyn.2016.05.003_bib84","first-page":"CD004861","article-title":"Types of progestogens in combined oral contraception: effectiveness and side-effects","author":"Lawrie","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"20","key":"10.1016\/j.bpobgyn.2016.05.003_bib85","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.bpobgyn.2016.05.003_bib86","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1210\/jc.2013-2374","article-title":"Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis","volume":"98","author":"Domecq","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.05.003_bib87","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.bpobgyn.2016.05.003_bib88","first-page":"3406","article-title":"Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study","volume":"80","author":"Azziz","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.bpobgyn.2016.05.003_bib89","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0015-0282(16)57532-3","article-title":"Combination gonadotropin-releasing hormone agonist and oral contraceptive therapy improves treatment of hirsute women with ovarian hyperandrogenism","volume":"63","author":"Elkind-Hirsch","year":"1995","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.05.003_bib90","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0015-0282(98)00414-2","article-title":"Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism","volume":"71","author":"Pazos","year":"1999","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.bpobgyn.2016.05.003_bib91","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0015-0282(16)56599-6","article-title":"The hyperandrogenic-insulin-resistant acanthosis nigricans syndrome: therapeutic response","volume":"61","author":"Azziz","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.05.003_bib92","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1749-6632.2010.05652.x","article-title":"Diagnosis and management of hirsutism","volume":"1205","author":"Escobar-Morreale","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.05.003_bib93","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1210\/jc.2007-2430","article-title":"Clinical review: antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials","volume":"93","author":"Swiglo","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.05.003_bib94","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1210\/jc.2007-2429","article-title":"Clinical review: insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials","volume":"93","author":"Cosma","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.bpobgyn.2016.05.003_bib95","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.05.003_bib96","first-page":"89","article-title":"Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial","volume":"85","author":"Moghetti","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.05.003_bib97","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial","volume":"86","author":"Azziz","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib98","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1210\/jc.2008-1133","article-title":"Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial","volume":"94","author":"Aroda","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib99","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2265.1990.tb00857.x","article-title":"Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases","volume":"32","author":"Kiddy","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.bpobgyn.2016.05.003_bib100","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.fertnstert.2005.10.054","article-title":"Obesity and androgens: facts and perspectives","volume":"85","author":"Pasquali","year":"2006","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.bpobgyn.2016.05.003_bib101","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/humrep\/deu096","article-title":"Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome","volume":"29","author":"Ezeh","year":"2014","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.bpobgyn.2016.05.003_bib102","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","author":"Nestler","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.bpobgyn.2016.05.003_bib103","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/1071-5576(94)00061-5","article-title":"The effects of insulin on 3 beta-hydroxysteroid dehydrogenase expression in human luteinized granulosa cells","volume":"2","author":"McGee","year":"1995","journal-title":"J\u00a0Soc Gynecol Investig"},{"issue":"6","key":"10.1016\/j.bpobgyn.2016.05.003_bib104","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.bpobgyn.2016.05.003_bib105","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-2265.2007.03105.x","article-title":"A\u00a0systematic review of commonly used medical treatments for hirsutism in women","volume":"68","author":"Koulouri","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"10.1016\/j.bpobgyn.2016.05.003_bib106","first-page":"CD007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","author":"Moran","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.bpobgyn.2016.05.003_bib107","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1210\/jc.2005-1490","article-title":"The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery","volume":"90","author":"Escobar-Morreale","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib108","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.soard.2005.02.008","article-title":"Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass","volume":"1","author":"Eid","year":"2005","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"10.1016\/j.bpobgyn.2016.05.003_bib109","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-0032-1328878","article-title":"Obesity and PCOS: implications for diagnosis and treatment","volume":"30","author":"Legro","year":"2012","journal-title":"Semin Reprod Med"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.05.003_bib110","first-page":"233","article-title":"A\u00a0prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women","volume":"80","author":"Wong","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib111","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/09513599609097901","article-title":"Comparison of flutamide and cyproterone acetate in the treatment of hirsutism: a randomized controlled trial","volume":"10","author":"Grigoriou","year":"1996","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2016.05.003_bib112","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0015-0282(98)00486-5","article-title":"Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects","volume":"71","author":"Fruzzetti","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.05.003_bib113","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000341822","article-title":"Hirsutism \u2013 from diagnosis to use of antiandrogens","volume":"40","author":"Unluhizarci","year":"2013","journal-title":"Front Horm Res"},{"issue":"6","key":"10.1016\/j.bpobgyn.2016.05.003_bib114","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0015-0282(97)00371-3","article-title":"Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism","volume":"68","author":"Erenus","year":"1997","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.bpobgyn.2016.05.003_bib115","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1530\/eje.0.1500351","article-title":"A\u00a0comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism","volume":"150","author":"Kelestimur","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.05.003_bib116","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-4632.2006.03079.x","article-title":"Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair","volume":"46","author":"Wolf","year":"2007","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.bpobgyn.2016.05.003_bib117","first-page":"1237","article-title":"Eflornithine cream combined with laser therapy in the management of unwanted facial hair growth in women: a randomized trial","volume":"32","author":"Smith","year":"2006","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.05.003_bib118","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2006.09.025","article-title":"A\u00a0randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women","volume":"57","author":"Hamzavi","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.05.003_bib119","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0738-081X(01)00200-0","article-title":"Hair removal","volume":"19","author":"Ramos-e-Silva","year":"2001","journal-title":"Clin Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.bpobgyn.2016.05.003_bib120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0190-9622(99)70181-7","article-title":"Methods of hair removal","volume":"40","author":"Olsen","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.bpobgyn.2016.05.003_bib121","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1346-8138.1995.tb03912.x","article-title":"A\u00a0comparative study of axillar hair removal in women: plucking versus the blend method","volume":"22","author":"Urushibata","year":"1995","journal-title":"J\u00a0Dermatol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.05.003_bib122","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0190-9622(95)91290-8","article-title":"Electrolysis: observations from 13 years and 140,000 hours of experience","volume":"33","author":"Richards","year":"1995","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2016.05.003_bib123","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1529-8019.2008.00220.x","article-title":"Physical means of treating unwanted hair","volume":"21","author":"Wanitphakdeedecha","year":"2008","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib124","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/09546634.2012.715239","article-title":"A\u00a0comparative study of hair removal at an NHS hospital: Luminette intense pulsed light versus electrolysis","volume":"25","author":"Harris","year":"2014","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00128071-200203020-00004","article-title":"Laser hair removal: guidelines for management","volume":"3","author":"Liew","year":"2002","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib126","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1586\/17434440.4.2.253","article-title":"Laser- and light-based hair removal: an update","volume":"4","author":"Goldberg","year":"2007","journal-title":"Expert Rev Med Devices"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.05.003_bib127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2003.582","article-title":"Lasers in dermatology: four decades of progress","volume":"49","author":"Tanzi","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.05.003_bib128","first-page":"CD004684","article-title":"Laser and photoepilation for unwanted hair growth","author":"Haedersdal","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.05.003_bib129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-3083.2005.01327.x","article-title":"Evidence-based review of hair removal using lasers and light sources","volume":"20","author":"Haedersdal","year":"2006","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2016.05.003_bib130","first-page":"249","article-title":"Laser-assisted hair removal in Asian skin: efficacy, complications, and the effect of single versus multiple treatments","volume":"29","author":"Hussain","year":"2003","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.05.003_bib131","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaad.2005.09.034","article-title":"Hair induction after laser-assisted hair removal and its treatment","volume":"54","author":"Kontoes","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib132","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/14628830050516470","article-title":"Hair reduction using a new intense pulsed light irradiator and a normal mode ruby laser","volume":"2","author":"Bjerring","year":"2000","journal-title":"J\u00a0Cutan Laser Ther"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.05.003_bib133","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/09546630310004171","article-title":"Comparative study on a single treatment response to long pulse Nd:YAG lasers and intense pulse light therapy for hair removal on skin type IV to VI\u2013is longer wavelengths lasers preferred over shorter wavelengths lights for assisted hair removal","volume":"14","author":"Goh","year":"2003","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"6","key":"10.1016\/j.bpobgyn.2016.05.003_bib134","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/bjd.12182","article-title":"Photoepilation with a diode laser vs. intense pulsed light: a randomized, intrapatient left-to-right trial","volume":"168","author":"Klein","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib135","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2133.2011.10695.x","article-title":"Long-pulsed Nd:YAG laser vs. intense pulsed light for hair removal in dark skin: a randomized controlled trial","volume":"166","author":"Ismail","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.bpobgyn.2016.05.003_bib136","first-page":"CD004425","article-title":"Combined oral contraceptive pills for treatment of acne","volume":"7","author":"Arowojolu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"43","key":"10.1016\/j.bpobgyn.2016.05.003_bib137","first-page":"2137","article-title":"[Acne vulgaris in connection with the use of progestagens in a hormonal IUD or a subcutaneous implant]","volume":"147","author":"Cohen","year":"2003","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib138","first-page":"CD000194","article-title":"Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne","author":"Brown","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib139","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2133.1986.tb05722.x","article-title":"Oral spironolactone: an effective treatment for acne vulgaris in women","volume":"115","author":"Muhlemann","year":"1986","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib140","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2133.1984.tb04045.x","article-title":"Oral spironolactone improves acne vulgaris and reduces sebum excretion","volume":"111","author":"Goodfellow","year":"1984","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2016.05.003_bib141","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jaad.2008.06.040","article-title":"An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients","volume":"59","author":"Thiboutot","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3 Suppl","key":"10.1016\/j.bpobgyn.2016.05.003_bib142","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1067\/S0190-9622(03)01152-6","article-title":"Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study","volume":"49","author":"Wolf","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib143","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1346-8138.2010.00969.x","article-title":"Efficacy of oral antibiotics on acne vulgaris and their effects on quality of life: a multicenter randomized controlled trial using minocycline, roxithromycin and faropenem","volume":"38","author":"Hayashi","year":"2011","journal-title":"J\u00a0Dermatol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2016.05.003_bib144","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0190-9622(84)80100-0","article-title":"Isotretinoin therapy for acne: results of a multicenter dose-response study","volume":"10","author":"Strauss","year":"1984","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.bpobgyn.2016.05.003_bib145","first-page":"CD007628","article-title":"Interventions for female pattern hair loss","volume":"5","author":"van Zuuren","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.bpobgyn.2016.05.003_bib146","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jaad.2010.09.724","article-title":"A\u00a0randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women","volume":"65","author":"Blume-Peytavi","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2016.05.003_bib147","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.2002.04798.x","article-title":"Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial","volume":"146","author":"Vexiau","year":"2002","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2016.05.003_bib148","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/jamafacial.2014.316","article-title":"A\u00a0review of medical and surgical treatment options for androgenetic alopecia","volume":"16","author":"Rousso","year":"2014","journal-title":"JAMA Facial Plast Surg"},{"issue":"3","key":"10.1016\/j.bpobgyn.2016.05.003_bib149","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2265.2000.00936.x","article-title":"Relapse of hirsutism following long-term successful treatment with oestrogen-progestogen combination","volume":"52","author":"Kokaly","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/1464727002000198781","article-title":"Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study","volume":"3","author":"Wild","year":"2000","journal-title":"Hum Fertil (Camb)"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.05.003_bib151","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1530\/EJE-13-0585","article-title":"Therapy in endocrine disease: treatment of hirsutism in the polycystic ovary syndrome","volume":"170","author":"Pasquali","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.05.003_bib152","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11892-007-0012-8","article-title":"Metabolic syndrome and cardiometabolic risk in PCOS","volume":"7","author":"Cussons","year":"2007","journal-title":"Curr Diab Rep"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693416300220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693416300220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T05:35:04Z","timestamp":1656480904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693416300220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":152,"alternative-id":["S1521693416300220"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2016.05.003","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgen excess: Investigations and management","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2016.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}